183 related articles for article (PubMed ID: 7379052)
1. Methotrexate and 7-hydroxymethotrexate: serum level monitoring by high-performance liquid chromatography.
Canfell C; Sadée W
Cancer Treat Rep; 1980 Jan; 64(1):165-9. PubMed ID: 7379052
[TBL] [Abstract][Full Text] [Related]
2. High-presssure liquid chromatographic determination of methotrexate and its major metabolite, 7-hydroxymethotrexate, in human plasma.
Watson E; Cohen JL; Chan KK
Cancer Treat Rep; 1978 Mar; 62(3):381-7. PubMed ID: 647697
[TBL] [Abstract][Full Text] [Related]
3. [Serum monitoring of methotrexate (MTX) and 7-hydroxymethotrexate concentrations in patients treated with MTX using high-pressure liquid chromatography (HPLC) and comparison of serum MTX levels between HPLC method and fluorescence polarization immunoassay (FPIA)].
Sakamoto S; Matsuhisa T; Miyoshi K; Naruse R; Urayama H; Shimokawa T; Okabe K; Toki H; Motoi M; Moriwaki S
Gan To Kagaku Ryoho; 1991 Jun; 18(7):1119-25. PubMed ID: 2053771
[TBL] [Abstract][Full Text] [Related]
4. Determination of serum methotrexate and 7-hydroxymethotrexate concentrations. Method evaluation showing advantages of high-performance liquid chromatography.
So N; Chandra DP; Alexander IS; Webster VJ; O'Gorman Hughes DW
J Chromatogr; 1985 Jan; 337(1):81-90. PubMed ID: 3884642
[TBL] [Abstract][Full Text] [Related]
5. High-performance liquid chromatographic and enzyme-inhibition assays of methotrexate concentrations in serum from patients receiving high-dose therapy: tight binding of some methotrexate to a protein that could be dihydrofolate reductase.
Iven H; Bartels H
Cancer Treat Rep; 1985; 69(7-8):825-32. PubMed ID: 4016793
[TBL] [Abstract][Full Text] [Related]
6. HPLC determination of methotrexate and its metabolite in serum.
Brandsteterová E; Seresová O; Miertus S; Reichelová V
Neoplasma; 1990; 37(4):395-403. PubMed ID: 2234201
[TBL] [Abstract][Full Text] [Related]
7. Interference of 7-hydroxymethotrexate with the determination of methotrexate in plasma samples from children with acute lymphoblastic leukemia employing routine clinical assays.
Fotoohi K; Skärby T; Söderhäll S; Peterson C; Albertioni F
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Mar; 817(2):139-44. PubMed ID: 15686977
[TBL] [Abstract][Full Text] [Related]
8. Simple and sensitive HPLC method for the fluorometric determination of methotrexate and its major metabolites in human plasma by post-column photochemical reaction.
Uchiyama M; Matsumoto T; Matsumoto T; Jimi S; Takamatsu Y; Tamura K; Hara S
Biomed Chromatogr; 2012 Jan; 26(1):76-80. PubMed ID: 21437923
[TBL] [Abstract][Full Text] [Related]
9. Formation of 7-hydroxymethotrexate polyglutamyl derivatives and their cytotoxicity in human chronic myelogenous leukemia cells, in vitro.
Fabre G; Goldman ID
Cancer Res; 1985 Jan; 45(1):80-5. PubMed ID: 2578101
[TBL] [Abstract][Full Text] [Related]
10. Analysis of methotrexate and 7-hydroxymethotrexate by high-pressure liquid chromatography.
Wisnicki JL; Tong WP; Ludlum DB
Cancer Treat Rep; 1978 Apr; 62(4):529-32. PubMed ID: 657149
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of methotrexate and 7-hydroxymethotrexate following infusions of high-dose methotrexate.
Breithaupt H; Küenzlen E
Cancer Treat Rep; 1982 Sep; 66(9):1733-41. PubMed ID: 6956440
[TBL] [Abstract][Full Text] [Related]
12. Identification and quantitation of methotrexate and methotrexate metabolites in clinical high-dose therapy by high pressure liquid chromatography and field desorption mass spectrometry.
Przybylski M; Preiss J; Dennebaum R; Fischer J
Biomed Mass Spectrom; 1982 Jan; 9(1):22-32. PubMed ID: 7037062
[TBL] [Abstract][Full Text] [Related]
13. [Highly sensitive analytical procedure for methotrexate and its main metabolite 7-hydroxymethotrexate in serum by high-performance liquid chromatography].
Hirai T; Kitamura M; Inoue Y
Yakugaku Zasshi; 1994 Aug; 114(8):602-10. PubMed ID: 7932104
[TBL] [Abstract][Full Text] [Related]
14. Determination of methotrexate in human serum by high-performance liquid chromatography combined with pseudo template molecularly imprinted polymer.
Liu X; Liu J; Huang Y; Zhao R; Liu G; Chen Y
J Chromatogr A; 2009 Oct; 1216(44):7533-8. PubMed ID: 19559443
[TBL] [Abstract][Full Text] [Related]
15. The influence of 7-OH methotrexate metabolite on clinical relevance of methotrexate determination.
Klapkova E; Kukacka J; Kotaska K; Suchanska I; Urinovska R; Prusa R
Clin Lab; 2011; 57(7-8):599-606. PubMed ID: 21888024
[TBL] [Abstract][Full Text] [Related]
16. A specific HPLC assay to determine the pharmacokinetics of methotrexate in patients.
Chen ML; McGuire WP; Lad TE; Chiou WL
Int J Clin Pharmacol Ther Toxicol; 1984 Jan; 22(1):1-6. PubMed ID: 6698654
[TBL] [Abstract][Full Text] [Related]
17. Method for the determination of blood methotrexate by high performance liquid chromatography with online post-column electrochemical oxidation and fluorescence detection.
Li H; Luo W; Zeng Q; Lin Z; Luo H; Zhang Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jan; 845(1):164-8. PubMed ID: 16890029
[TBL] [Abstract][Full Text] [Related]
18. Monitoring methotrexate in clinical samples from cancer patients during chemotherapy with a LSPR-based competitive sensor.
Zhao SS; Bichelberger MA; Colin DY; Robitaille R; Pelletier JN; Masson JF
Analyst; 2012 Oct; 137(20):4742-50. PubMed ID: 22943049
[TBL] [Abstract][Full Text] [Related]
19. Trace analysis of methotrexate and 7-hydroxymethotrexate in human plasma and urine by a novel high-performance liquid chromatographic method.
Beck O; Seideman P; Wennberg M; Peterson C
Ther Drug Monit; 1991 Nov; 13(6):528-32. PubMed ID: 1771651
[TBL] [Abstract][Full Text] [Related]
20. Analysis of methotrexate and 7-hydroxymethotrexate by high-performance liquid chromatography and preliminary clinical studies.
Collier CP; MacLeod SM; Soldin SJ
Ther Drug Monit; 1982; 4(4):371-80. PubMed ID: 6760471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
